Skip to Content

Join the 'Brain Tumor' group to help and get support from people like you.

Brain Tumor News

Related terms: Brain Cancer, Brain Tumor, metastatic, Cancer, Brain, Intracranial Tumors

Sen. John McCain Has Brain Cancer

Posted 7 days ago by Drugs.com

THURSDAY, July 20, 2017 – Sen. John McCain, a respected longtime lawmaker, former prisoner of war and the Republican presidential nominee in 2008, has been diagnosed with an aggressive brain cancer. A statement released by McCain's office Wednesday night said the cancer, known as a glioblastoma, was discovered after a procedure to remove a blood clot above his left eye last week at Mayo Clinic Hospital in Phoenix. "Subsequent tissue pathology revealed that a primary brain tumor known as a glioblastoma was associated with the blood clot," the statement said. "Treatment options may include a combination of chemotherapy and radiation." McCain, 80, who has represented Arizona in the Senate since 1986, is known for his independent nature. He was a former Navy pilot who was captured, tortured and held for more than 5 years as a prisoner during the Vietnam War. "Senator John McCain has always ... Read more

Related support groups: Cancer, Brain Tumor, Glioblastoma Multiforme

Insured, But Still Barred From Top-Tier Cancer Centers

Posted 7 days ago by Drugs.com

THURSDAY, July 20, 2017 – Choosing a cheaper health plan could cost you access to cream-of-the-crop cancer doctors and facilities, a new study reports. Less-expensive "narrow network" health plans are much less likely to cover treatment by doctors at centers affiliated with the U.S. National Cancer Institute, said study lead author Laura Yasaitis. "We found that the narrower networks were more likely to systematically exclude NCI-affiliated physicians," said Yasaitis, a postdoctoral researcher with the University of Pennsylvania School of Medicine. "The oncologists they included in their networks were about half as likely to be NCI-affiliated as those they excluded." NCI-Designated Cancer Centers are the nation's top-flight facilities for cancer care, and studies have shown that patients treated at these centers tend to have better outcomes, Yasaitis said. Access to these centers is ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Brain Tumor, Cervical Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer

Senator McCain Faces a Tough Cancer Foe

Posted 7 days ago by Drugs.com

THURSDAY, July 20, 2017 – Sen. John McCain faces an uphill battle fighting the aggressive cancer discovered in his brain last week, experts say. The cancer, glioblastoma, is the most common malignant tumor that originates in brain cells, as opposed to cancers that spread to the brain from elsewhere in the body, said Dr. Manmeet Ahluwalia, dean of the Cleveland Clinic's Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center. But it's a very tough cancer to treat. Glioblastoma is difficult to surgically remove, resists attempts to kill it with radiation and chemotherapy, and nearly always comes back, cancer experts said. "The tumor many times responds to treatment initially but it tends to grow back," said Dr. Kurt Jaeckle, a neuro-oncologist and co-director of the Gerald J. Glasser Brain Tumor Center at Overlook Medical Center's Atlantic Neuroscience Institute in New Jersey. "It's ... Read more

Related support groups: Cancer, Brain Tumor, Glioblastoma Multiforme

Many Terminal Cancer Patients Remain in Denial

Posted 8 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – Nearly 10 percent of patients with terminal cancer don't want to know they're dying, which can make their final days more difficult, a new study finds. Unwillingness to face poor prospects can lead to unnecessary treatments and keep patients from making end-of-life plans, the researchers reported recently in The Oncologist. "Health care professionals should appropriately assess patients' readiness for prognostic information," said study leader Siew-Tzuh Tang, a professor at Chang Gung University School of Nursing in Taiwan. Doctors should respect patients' reluctance to confront their poor prognosis if they are not ready to know, "but sensitively coach them to cultivate their accurate prognostic awareness," Tang said in a journal news release. The study involved nearly 250 terminal cancer patients in Taiwan. They were questioned several times over their last ... Read more

Related support groups: Anxiety, Generalized Anxiety Disorder, Anxiety and Stress, Cancer, Post Traumatic Stress Disorder, Social Anxiety Disorder, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention

Doctors' Group Offers Ideas for Easing Cancer Costs

Posted 8 days ago by Drugs.com

WEDNESDAY, July 19, 2017 – New cancer drugs routinely cost $100,000 a year or more, and older cancer drugs are rising in price, too. Now, the American Society of Clinical Oncology (ASCO) has some suggestions for easing patients' money woes. The proposals include allowing Medicare to negotiate drug prices, legalizing the importation of drugs, and adopting bundled, or group, payment programs. In the new policy statement, ASCO also says it supports creation of a panel of "stakeholders" in health care to determine the effectiveness of its proposals. Such a group might also outline a uniform approach for assessing the value of drugs. "In what, undoubtedly, is one of the most difficult times in their lives, individuals with cancer should be focused on getting the best care possible, not worrying about financial strain on their families," said Dr. Clifford Hudis. He's CEO of ASCO, a leading ... Read more

Related support groups: Cancer, Depo-Provera, Provera, Methotrexate, Breast Cancer, Lupron, Prostate Cancer, Medroxyprogesterone, Tamoxifen, Arimidex, Fluorouracil, Lupron Depot, Femara, Gleevec, Lung Cancer, Colorectal Cancer, Votrient, Anastrozole, Brain Tumor, Letrozole

FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas

Posted 22 Jun 2017 by Drugs.com

June 6, 2017 - The U.S. Food and Drug Administration (FDA) has approved Gleolan [aminolevulinic acid hydrochloride (ALA HCl)] as an optical imaging agent indicated in patients with gliomas (suspected World Health Organization Grades III or IV on preoperative imaging) as an adjunct for the visualization of malignant tissue during surgery. The approved recommended reconstituted oral dose of Gleolan is 20 mg/kg administered 3 hours (range 2 to 4 hours) prior to induction of anesthesia. During neurosurgery, Gleolan is used with an operating microscope adapted with a blue emitting light source and filters for excitation light of wavelength 375 to 440 nm, and observation at wavelengths of 620 to 710 nm. Due to the risk of phototoxic reactions, do not administer phototoxic drugs for 24 hours during the perioperative period. Reduce exposure to sunlight or room lights for 24 hours ... Read more

Related support groups: Surgery, Brain Tumor, Diagnosis and Investigation, Aminolevulinic Acid, Gleolan

'Electric Cap' Might Help Fight a Deadly Brain Tumor

Posted 3 Apr 2017 by Drugs.com

MONDAY, April 3, 2017 – A cap that zaps tumors with electrical currents may boost survival in patients with a deadly brain cancer, new research suggests. The device is worn on the head and exposes glioblastoma cells to a rapidly alternating sequence of low-intensity electrical frequencies. This interrupts cancer cells' ability to function, the researchers said. According to study author Dr. Roger Stupp, a professor of neurological surgery at Northwestern University's Feinberg School of Medicine in Chicago, the cap is "an entirely different way to treat cancer. "Our results demonstrate a proof-of-concept that this treatment modality actually works, and can prevent tumor cells from growing and dividing," he added. "And it does increase the survival rate at two years, three years, and even at five years, in a substantial amount," said Stupp, who noted that the cap is "the first treatment ... Read more

Related support groups: Brain Tumor, Glioblastoma Multiforme

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Osteosarcoma, Endometrial Cancer, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Cervical Cancer, Melanoma - Metastatic

Seniors With Brain Cancer May Have Better Treatment Option

Posted 15 Mar 2017 by Drugs.com

WEDNESDAY, March 15, 2017 – Combined chemotherapy and radiation treatment appears to extend the lives of older patients with brain cancer, new research finds. The study involved more than 560 older patients with glioblastoma, the most common malignant brain cancer in adults. The average age of disease onset is 65 and there is no cure, according to the study. On average, patients who received the chemotherapy pill temozolomide plus a short course of radiation therapy survived two months longer than those who underwent radiation alone, an international team of researchers found. And, many patients in the combination treatment group survived nearly 14 months – about twice that compared to those who received radiation alone, the researchers reported. "Everyone benefited to a varying degree," said co-principal investigator Dr. Normand Laperriere. "There has been no clear standard of care ... Read more

Related support groups: Cancer, Brain Tumor, Temodar, Glioblastoma Multiforme, Diagnosis and Investigation, Malignant Glioma, Temozolomide

Study Casts Doubt on a Brain Cancer's Link to Herpes

Posted 8 Mar 2017 by Drugs.com

TUESDAY, March 7, 2017 – There's no link between a common type of herpes virus and aggressive brain cancers, according to a new study that refutes earlier reports. Johns Hopkins researchers analyzed tumor tissue from 125 patients with aggressive brain cancers called gliomas. Ninety-nine of the samples were from adults. Twenty-six were from children. The researchers found no evidence of cytomegalovirus (CMV), a type of herpes virus, in the tumor tissue. Further studies are needed to rule out any role for CMV in these brain cancers. But the new findings suggest little likelihood of any connection, the researchers said. "We have found no evidence of CMV in these tissues, and if there is no virus, targeting that virus to affect cancer using antiviral drugs or tailored vaccines doesn't make biological sense," said Dr. Angelo De Marzo, a professor of pathology, oncology and urology at Johns ... Read more

Related support groups: Brain Tumor, Cytomegalovirus (CMV) Infection, Malignant Glioma

Cancer Survivors Gain From Web-Based Health Care

Posted 10 Feb 2017 by Drugs.com

FRIDAY, Feb. 10, 2017 – Online- and phone-based health care offers a number of benefits for cancer survivors, British researchers report. The new study looked at previous research on cancer survivors' experiences with online and phone health contacts – what the researchers call telehealth. The review found that patients liked the flexibility and convenience of this method of staying in touch with their care providers because they could do so in a familiar, comfortable setting and with minimum disruption to their lives. The perceived anonymity of telehealth reduced patients' sense of vulnerability and some said they were more comfortable raising concerns in this setting than in face-to-face appointments. Negative aspects of telehealth mentioned by patients included not being able to meet their health care providers in person, while other patients said they couldn't use the service due ... Read more

Related support groups: Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Skin Cancer, Ovarian Cancer, Small Cell Lung Cancer, Bladder Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Testicular Cancer, Breast Cancer - Palliative, Zollinger-Ellison Syndrome, Wilms' Tumor, Solid Tumors

Chemo Drug May Combat Serious Brain Tumor After All

Posted 22 Dec 2016 by Drugs.com

THURSDAY, Dec. 22, 2016 – Some patients with a deadly brain tumor may respond to drugs previously believed to be ineffective against the cancer, a new study says. The findings highlight the importance of properly categorizing glioblastoma tumors in order to best tailor treatment to each patient, according to the researchers. Glioblastoma tumors are diagnosed in about 12,000 people in the United States each year. Half of patients with this type of tumor die within 15 months of diagnosis, the researchers said. There was hope that lives could be extended with a class of chemotherapy drugs called anti-angiogenic compounds. These drugs were designed to block the growth of new blood vessels in the tumor in an attempt to starve the tumor of oxygen and nutrients. But recently published findings from two large clinical trials concluded that an anti-angiogenic drug called bevacizumab did not ... Read more

Related support groups: Cancer, Brain Tumor, Avastin, Glioblastoma Multiforme, Bevacizumab

Cancer Patients in Poorer Countries Often Go Without Radiation

Posted 2 Oct 2016 by Drugs.com

THURSDAY, Sept. 29, 2016 – Many cancer patients in low- and middle-income nations who would benefit from radiation treatment don't receive it, a new study finds. "In Ghana and the Philippines, for example, about eight in 10 cancer patients who need radiation therapy will not receive needed treatment," said study co-author Dr. Elena Fidarova, a researcher at the International Atomic Energy Agency in Vienna, Austria. She and her colleagues analyzed data from nine nations: Costa Rica, Ghana, Malaysia, the Philippines, Romania, Serbia, Slovenia, Tunisia and Uruguay. Overall, about five out of 10 cancer patients in these countries require radiation therapy to shrink tumors and kill cancer cells. But up to half of them do not have access to it, the researchers found. In individual nations, the rates of patients who can benefit from radiation therapy but do not receive it ranged from 18 to 82 ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Brain Tumor, Bladder Cancer, History - Radiation Therapy

Childhood Cancer Death Rates Continue to Fall: CDC

Posted 16 Sep 2016 by Drugs.com

FRIDAY, Sept. 16, 2016 – The number of U.S. children who die from cancer has fallen 20 percent since 1999, and leukemia is no longer the top killer, a new federal government report shows. The decline continues a trend that began back in the 1970s, experts said. What's new is that leukemia – the most common type of childhood cancer – is no longer the leading cause of cancer deaths. Survival among children with leukemia has improved to the degree that brain cancer now tops the list. "It had been leukemia for decades, but only recently has there been this switch," said lead researcher Sally Curtin, who is with the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS). It's not that deaths from childhood brain cancer are rising, according to Curtin. Instead, the rate has remained stubbornly stable, while leukemia deaths keep declining, she ... Read more

Related support groups: Cancer, Hairy Cell Leukemia, Leukemia, Brain Tumor

Strides Made in Treating Childhood Cancer: Report

Posted 11 Sep 2016 by Drugs.com

FRIDAY, Sept. 9, 2016 – Significant progress has been made in treating childhood cancers, but more needs to be done to fight tougher cancers and protect the long-term health of survivors, a new report says. In 2016, more than 14,600 children aged 19 and younger will be diagnosed with some form of pediatric cancer, and 1,850 will die, according to the American Cancer Society (ACS), which compiled the report with the Alliance for Childhood Cancer. "The numbers here tell a compelling story," said Katherine Sharpe, senior vice president of patient and caregiver support at the ACS. "We have seen significant progress when it comes to developing effective treatments for a variety of pediatric cancer sites and ultimately saving lives," she said in an ACS news release. "But when we expand our view to look at all pediatric cancers, as well as long-term health and survival, it becomes clear that ... Read more

Related support groups: Cancer, Leukemia, Brain Tumor, Neuroblastoma

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

Glioblastoma Multiforme, Pituitary Tumor, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Malignant Glioma, Angioblastoma, Cancer

Related Drug Support Groups

methotrexate, Afinitor, cisplatin, cyclophosphamide, everolimus, Platinol, lomustine, Zortress, Afinitor Disperz, view more... Gleostine, Gliadel, BiCNU, carmustine, CeeNU, Platinol-AQ